Literature DB >> 505365

Intravascular coagulation in autopsy cases with liver diseases.

K Oka, K Tanaka.   

Abstract

184 autopsy cases with liver diseases were examined clinicopathologically with special reference to the incidence and distribution of microthrombi and classic thrombi in various organs. Microthrombi and/or classic thrombi were found in one or more organs in 50.0% to 59.4% of the patients with various liver diseases. But only 4 among 184 patients had many microthrombi in more than three organs and the incidence of disseminated intravascular coagulation seemed to be low in autopsy cases with liver diseases. Incidence of microthrombi showed no significant difference in the groups with and without portal vein thrombosis. Hemorrhage in the upper alimentary tracts of the patients with liver cirrhosis did not seem to develop by disseminated intravascular coagulation. Consumption of clotting factors in liver diseases seemed to occur by thrombus formation in portal vein and esophageal varices and by hemorrhage in various organs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 505365

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Pulmonary platelet aggregates: possible cause of sudden peroperative death in adults undergoing liver transplantation.

Authors:  E A Sankey; J Crow; S V Mallett; R J Alcock; L More; A K Burroughs; K Rolles
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

2.  Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver.

Authors:  F Violi; D Ferro; S Basili; A D'Angelo; G Mazzola; C Quintarelli; C Cordova
Journal:  BMJ       Date:  1994-07-23

3.  Antibodies to phospholipid in alcoholic liver disease.

Authors:  G Bird; P Mills; D Smith; J Runcie
Journal:  BMJ       Date:  1994-10-29

Review 4.  Pivotal role of ADAMTS13 function in liver diseases.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 5.  Portal vein thrombosis in liver cirrhosis.

Authors:  Filippo Luca Fimognari; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

6.  Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.

Authors:  Y Kang; J H Lewis; A Navalgund; M W Russell; F A Bontempo; L S Niren; T E Starzl
Journal:  Anesthesiology       Date:  1987-06       Impact factor: 7.892

7.  A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis.

Authors:  Bing He; Hao Zhang; Tieliu Shi
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

8.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18

Review 9.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.